Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on October 1, 2026

Oct. 1, 2026

The Sales Training Services Market Is Projected to Experience Robust Growth at a 9.8% CAGR Through 2030

Indeterminate EIN Presswire

Oct. 1, 2026

The Semiconductor Wet Chemicals Market is projected to grow at a 7.2% CAGR, reaching a value of $5.05 billion by 2030.

Indeterminate EIN Presswire

Oct. 1, 2026

Omphalis Launches Voice Conversations Grounded in the Sources Readers Choose

Indeterminate EIN Presswire

Oct. 1, 2026

Pasqal Appoints Florence Lao as Chief Legal Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Classie launches Supervise to track, control and account for enterprise AI agents in real time

Indeterminate GlobeNewswire

Oct. 1, 2026

Rocket Doctor AI to Present at the 2026 CANTech Letter Conference in Toronto

Indeterminate GlobeNewswire

Oct. 1, 2026

Capitolis Wins 2026 GlobalCapital Derivatives Awards for Optimization Service of the Year – Americas, Europe, and Asia

Indeterminate GlobeNewswire

Oct. 1, 2026

Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

HydroGraph to Showcase Fractal Graphene Paste™ at The Advanced Materials Show USA

Indeterminate GlobeNewswire

Oct. 1, 2026

Sophos Launches CISO Advantage, Bringing CISO-Level Security Strategy Within Reach of Every Organization

Indeterminate GlobeNewswire

Oct. 1, 2026

Genius Group CEO Roger Hamilton Buys 1,000,000 Company Shares on the Open Market

Indeterminate GlobeNewswire

Oct. 1, 2026

Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3

Indeterminate GlobeNewswire

Oct. 1, 2026

“It’s NOT Geological!”: Long-Awaited Preliminary Report From Defense Scientist Reveals “Man-made Object” Beneath the Surface of Durupinar

Indeterminate GlobeNewswire

Oct. 1, 2026

Anytime AI 3.0 Launches Agentic Coworkers That Finish Casework for Complex Plaintiff Litigation

Indeterminate GlobeNewswire

Oct. 1, 2026

Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)

Indeterminate GlobeNewswire

Oct. 1, 2026

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Indeterminate GlobeNewswire

Oct. 1, 2026

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Indeterminate GlobeNewswire